Diabetic encephalopathy (DE) is one of
complications of diabetes mellitus.
Carnosine is a
dipeptide composed of β-
alanine and
l-histidine. Study has shown that
carnosine could ameliorate
cognitive impairment in animal model with
diabetes mellitus. However, the mechanism remains unclear. An animal model of
type 2 diabetes (db/db mice) was used in this study. The animals were treated with
0.9% saline or
carnosine (100 mg/kg) for 8 weeks. Morris water maze was tested after
drug administration. Oxidative stress-related factors
malondialdehyde (MDA),
superoxide dismutase (SOD),
catalase (CAT),
glutathione peroxidase (GSH-PX), and pro-inflammatory factors
inducible nitric oxide synthase (iNOS) were measured. Synapse-related
protein postsynaptic density 95 (PSD95) and
brain-derived neurotrophic factor (
BDNF) were detected by western blot. Besides, the expressions of
sirtuin 6 (SIRT6), binding
immunoglobulin protein (BIP),
protein kinase R-like endoplasmic reticulum
kinase (PERK), phospho-
protein kinase R-like endoplasmic reticulum
kinase (P-PERK),
inositol-requiring enzyme-1α (IRE1α), phospho-
inositol-requiring enzyme-1α (P-IRE1α),
activating transcription factor 6 (ATF6), and
C/EBP-homologous protein (CHOP) in the hippocampus of the brain were detected. The results showed that treatment with
carnosine ameliorated
cognitive impairment in db/db mice.
Carnosine reduced neuronal oxidative stress damage and iNOS expression in db/db mice. Meanwhile,
carnosine relieved neurodegeneration in the hippocampus of db/db mice. Furthermore,
carnosine promoted the expression of SIRT6 and reduced the expressions of endoplasmic reticulum (ER)-related factors (BIP, P-PERK, P-IRE1α, ATF6, and CHOP). In conclusion, these data suggested that the protective effect of
carnosine against DE might be related to SIRT6/ER stress pathway.